Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma

Gut. 2010 Nov;59(11):1587-8. doi: 10.1136/gut.2009.196428. Epub 2010 Aug 23.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • ErbB Receptors / antagonists & inhibitors
  • Fatal Outcome
  • Humans
  • Ileal Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab